Document is current
Any future updates will be listed below
-
Authors
Alexe, Amalia
Wurst, Keele
Balramsingh-Harry, Leesha
Apara, Olatayo
Abramova, Nadezda
Eisele, Osa
Fernandes, Maria Fernanda Scantamburlo
Garg, Anju
Kovacs, Birgit
Lewis, David
- License Information
-
More Information
Article History
Received: 5 July 2024
Accepted: 19 December 2024
First Online: 22 February 2025
Declarations
:
: Amalia Alexe is a full-time employee of Advanced Accelerator Applications, a Novartis Company, and holds shares in Incyte and Novartis. Dr. Wurst is a full-time employee of GlaxoSmithKline and holds shares in GlaxoSmithKline. Leesha Balramsingh-Harry is a full-time employee of Hoffman LaRoche Ltd. and holds shares in Hoffman-LaRoche AG. Dr. Apara is a full-time employee of Merck & Co Inc. and holds shares in Merck & Co Inc. Dr. Nadezda Abramova is a full-time employee of Merck Healthcare KGaA. Dr. Eisele is a full-time employee of Amgen Inc. and holds shares in Amgen. Dr. Maria Fernanda Scantamburlo Fernandes is a full-time employee of Eli Lilly and holds shares in Eli Lilly. Dr. Anju Garg is a full-time employee of Sanofi and holds shares in Sanofi. Dr. Birgit Kovacs was a full-time employee of Boehringer Ingelheim Pharmaceuticals and held shares in Eli Lilly at the time this manuscript was written. Dr. Lewis is a full-time employee of Novartis Pharma AG and holds shares in GlaxoSmithKline and Novartis.
